Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events symbols : BLUE save search
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 0.7%
H: 3.85%
C: 2.8%
update commercial program financial
bluebird bio to Host Second Quarter 2023 Financial Results Conference Call and Provide Commercial Update
Published: 2023-07-25 (Crawled : 13:00) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 0.0%
H: 6.77%
C: -1.82%
conference update commercial financial results
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones and 2023 Financial Outlook Ahead of Company Presentation at 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-09 (Crawled : 12:20) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 1.15%
H: 0.44%
C: -5.16%
conference commercial program presentation financial update
bluebird bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-05 (Crawled : 14:20) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: -0.53%
H: 7.53%
C: 4.1%
conference
bluebird bio Announced September Investor Events
Published: 2022-08-29 (Crawled : 13:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.77%
H: 0.34%
C: -0.92%
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: -1.35%
H: 5.81%
C: 0.85%
bluebird bio to Provide Update on Program Milestones and 2022 Financial Outlook at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-11 (Crawled : 13:00) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: 0.0%
milestone
2seventy bio Announces Upcoming Investor Events
Published: 2021-09-13 (Crawled : 13:00) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 0.06%
H: 4.08%
C: 2.24%
betibeglogene autotemcel (beti-cel) One-Time Gene Therapy for β-thalassemia Continues to Demonstrate Durable Efficacy Across Pediatric and Adult Patient Populations and All Genotypes in Data Presented at EHA2021 Virtual
Published: 2021-06-11 (Crawled : 11:00) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 1.06%
H: 0.35%
C: -0.44%
gene therapy therapy gene therapies cel
bluebird bio Announces May Investor Events
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 0.57%
H: 0.99%
C: -1.89%
bluebird bio to Present at Cowen Health Care Conference
Published: 2021-02-26 (Crawled : 14:00) - biospace.com/
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 0.43%
H: 10.27%
C: 10.13%
conference presentation health
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.